- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.07. | Cases of skin cancer set to reach 263,000 in 2035 according to new report | ||
| 29.07. | Former Serviceplan Health Managing Partner launches new consultancy | ||
| 28.07. | Havas Lynx expands Claire Knapp's remit to oversee Havas Lynx New York | ||
| 28.07. | Johnson & Johnson commits $5.5bn to end remaining talc litigation | ||
| 27.07. | EMA recommends granting marketing authorisation approval for Nezglyal | ||
| 27.07. | MAD World Summit 2026: where the future of workplace well-being takes centre stage | ||
| 24.07. | AstraZeneca's Trixeo recommended by CHMP for approval in EU for asthma | ||
| 24.07. | ELRIG appoints Hitesh Sanganee and Marcus Schindler to Scientific Advisory Board | ||
| 23.07. | Pfizer's Talzenna plus Xtandi gets FDA Priority Review for metastatic prostate cancer | ||
| 23.07. | Stoke Therapeutics appoints Thomas McCauley as Chief Scientific Officer | ||
| 22.07. | Takeda's zasocitinib shows high rates of skin clearance in phase 3 psoriasis studies | ||
| 22.07. | Richmond Pharmacology appoints Daniel Chapple as Commercial Director | ||
| 21.07. | Almirall's paediatric registration of Ebglyss for atopic dermatitis gets EMA acceptance | ||
| 21.07. | The Bloc appoints Jon Chapman as European Executive Creative Director | ||
| 20.07. | Camena Bioscience appoints Gregory McGuinness as CEO | ||
| 20.07. | Lilly to acquire AtaiBeckley in deal worth $2.8bn | ||
| 16.07. | POP Health appoints Stephanie O'Hagan as Senior Director | ||
| 16.07. | Veradermics' oral treatment for female pattern hair loss delivers positive study results | ||
| 15.07. | Biogen and Eisai's Leqembi study shows nearly 83% of early Alzheimer's patients remained stable or improved | ||
| 15.07. | Alzheimer's groups call for urgent global focus on women's brain health | ||
| 14.07. | Cherry appoints Peter Henshaw as new Managing Director | ||
| 14.07. | AstraZeneca agrees on $1.5bn deal with Dizal Pharmaceutical | ||
| 13.07. | Bristol Myers Squibb's New Drug Application for mezigdomide accepted by FDA | ||
| 13.07. | Exonate appoints Olav Hellebø as CEO | ||
| 10.07. | Boehringer Ingelheim's Jascayd approved by MHRA for idiopathic pulmonary fibrosis |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.